Clinical Trial Update: EXCELLENT (EXpanded CELL ENdocardiac Transplantation) [Phase 2]

View source ↗

Summary

The Phase 2 EXCELLENT trial evaluating expanded cell endocardial transplantation for acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Expanded CELL ENdocardiac Transplantation (EXCELLENT) therapy

Snippet

Sponsor: CellProthera | Conditions: Acute Myocardial Infarction | Phase 2 | Status: COMPLETED